Neuphoria Therapeutics Inc. (NEUP)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
Here's Why Momentum in Neuphoria Therapeutics Inc. (NEUP) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, Neuphoria Therapeutics Inc. (NEUP) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Neuphoria Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 11,222 | $49,040 | $42,868.04 | -$6,171.96 | -12.59% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 3 | $13 | $11.85 | -$1.15 | -8.85% |
Neuphoria Therapeutics Inc. (NEUP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Neuphoria Therapeutics Inc. ever had a stock split?
Neuphoria Therapeutics Inc. Profile
| Pharmaceuticals Industry | Healthcare Sector | Spyridon Papapetropoulos CEO | NASDAQ (NMS) Exchange | 64136E102 CUSIP |
| US Country | 8 Employees | - Last Dividend | 24 Dec 2024 Last Split | - IPO Date |
Overview
Neuphoria Therapeutics Inc. stands at the forefront of the biotech industry, spearheading the research and development of groundbreaking therapeutics catered to the mental health sector. With an unwavering commitment to fulfilling the unaddressed needs in mental healthcare, the company dedicates its expertise to combating prevalent conditions such as depression and anxiety disorders. These ailments, which impact millions of individuals across the globe, are the focus of Neuphoria’s innovative approach. By harnessing state-of-the-art technologies and fostering collaborative research efforts, the company endeavors to usher in a new era of mental health care options. The implications of Neuphoria’s work within the biotech field are profound, as it fuels a burgeoning demand for advanced and specialized treatment methodologies. As a pioneer in the quest for mental health breakthroughs, Neuphoria Therapeutics plays a crucial role in enhancing the lives of those affected, marking its significance as a driving force behind the evolution of healthcare solutions.
Products and Services
Neuphoria Therapeutics Inc. provides a diversified portfolio of products and services, all aimed at revolutionizing mental health care through innovation. Each offering is designed with the intent to address the complex challenges faced by individuals with mental health conditions, promising a future of effective and accessible treatments:
- Innovative Therapeutic Solutions - At the core of Neuphoria’s product lineup are its novel therapeutic candidates targeting depression and anxiety disorders. These are developed using cutting-edge research methodologies and technological advancements, aiming to create more efficacious and safer treatment alternatives to conventional therapies. The focus is on tailoring interventions that can significantly improve patient outcomes and overall quality of life.
- Collaborative Research Programs - Recognizing the importance of interdisciplinary collaboration in advancing mental health care, Neuphoria engages in strategic partnerships with academic institutions, pharmaceutical companies, and research organizations. These collaborations are designed to accelerate the development process of new therapeutics by pooling resources, knowledge, and expertise. Through such synergies, Neuphoria aims to foster innovation and expedite the introduction of transformative treatments to the market.
